Skip to Main content Skip to Navigation
Journal articles

Prior caspofungin exposure in patients with hematological malignancies is a risk factor for subsequent fungemia due to decreased susceptibility in Candida spp.: a case-control study in Paris, France.

Abstract : Infections due to caspofungin-resistant Candida isolates in patients exposed to caspofungin therapy are increasing. We report here a nested case-control study which aimed at identifying factors associated with bloodstream infections caused by Candida spp. having reduced susceptibility to caspofungin (CRSC) in adults suffering from hematological malignancies. In univariate and multivariate analyses, infections with CRSC were associated with caspofungin exposure in the previous 30 days (odds ratio [OR] = 5.25; 95% confidence interval [95% CI], 1.68-16.35) and with an age of ≤ 65 years (OR = 3.27; 95% CI, 1.26-8.50).
Document type :
Journal articles
Complete list of metadata

https://hal.archives-ouvertes.fr/hal-00818510
Contributor : Muriel Cornet Connect in order to contact the contributor
Submitted on : Saturday, April 27, 2013 - 4:12:24 PM
Last modification on : Thursday, April 7, 2022 - 10:10:30 AM

Links full text

Identifiers

Citation

Elodie Blanchard, Olivier Lortholary, Karine Boukris-Sitbon, Marie Desnos-Ollivier, Françoise Dromer, et al.. Prior caspofungin exposure in patients with hematological malignancies is a risk factor for subsequent fungemia due to decreased susceptibility in Candida spp.: a case-control study in Paris, France.. Antimicrobial Agents and Chemotherapy, American Society for Microbiology, 2011, 55 (11), pp.5358-61. ⟨10.1128/AAC.00690-11⟩. ⟨hal-00818510⟩

Share

Metrics

Record views

614